APA (7th ed.) Citation

Höglund, K., Kern, S., Zettergren, A., Börjesson-Hansson, A., Zetterberg, H., Skoog, I., & Blennow, K. (2017). Preclinical amyloid pathology biomarker positivity: Effects on tau pathology and neurodegeneration. Translational psychiatry, 7(1), e995. https://doi.org/10.1038/tp.2016.252

Chicago Style (17th ed.) Citation

Höglund, K., S. Kern, A. Zettergren, A. Börjesson-Hansson, H. Zetterberg, I. Skoog, and K. Blennow. "Preclinical Amyloid Pathology Biomarker Positivity: Effects on Tau Pathology and Neurodegeneration." Translational Psychiatry 7, no. 1 (2017): e995. https://doi.org/10.1038/tp.2016.252.

MLA (9th ed.) Citation

Höglund, K., et al. "Preclinical Amyloid Pathology Biomarker Positivity: Effects on Tau Pathology and Neurodegeneration." Translational Psychiatry, vol. 7, no. 1, 2017, p. e995, https://doi.org/10.1038/tp.2016.252.